First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent
Winnie Bergstedt, Pernille N. Tingskov, Birgit Thierry-Carstensen et al. · 2010
Read First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent by Winnie Bergstedt, Pernille N. Tingskov, Birgit Thierry-Carstensen et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011277.txt.
Description
Bergstedt, Tingskov, Thierry-Carstensen and colleagues ran a first human trial in PLOS ONE in 2010. Tuberculosis skin tests are old and often unclear, since prior BCG vaccination confuses results. The team tested a new reagent combining two proteins specific to the TB germ in volunteers for the first time.
A specific skin test could catch TB sooner and sort true infection from vaccine effects. That distinction matters in countries where BCG is routine. The trial checks safety and response as first steps toward clinic use. Better detection helps curb spread by finding infectious people earlier.
Catalog record
| CREATOR | Winnie Bergstedt, Pernille N. Tingskov, Birgit Thierry-Carstensen et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011277